Merck’s strong oncology gains, 4% yield, and low PEG ratio support its value case despite sector risks and patent concerns.

If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has ...

Shares of UnitedHealth Group Inc. (NYSE: UNH) climbed 2.81% in Monday's pre-market trading session, extending Friday's gain ...

UnitedHealth Group Incorporated stocks jumped sharply, riding a wave of investor enthusiasm. Berkshire Hathaway's new $1.57B ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her “Buy” rating, expecting long-term value despite ...

Berkshire Hathaway recently filed its second-quarter 13F form, revealing its stock holdings at the end of June.